Henry Christian O's Form 4/A amendment
AmendedGinkgo Bioworks Holdings, Inc. (DNA) · filed Oct 6, 2023
- Accession no.
- 0001127602-23-025684
- Filed
- Oct 6, 2023
- Trade date
- Oct 2, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Oct 4, 2023
This filing lists 1 non-derivative transaction. Open-market sales total $8.01K. It was filed 4 days after the trade.
This amendment replaces 0001127602-23-025520 (filed Oct 4, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henry Christian OCIK 0001263805 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2023 | Class A Common Stock | SSaleDisposed | −4,499 | $1.78 | −$8,008.22 | 1,238,878 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units.
Remarks
This Form 4 amends and restates the Form 4 filed by the Reporting Person on October 4, 2023 to correct an error in Table I.